{"groups":[{"description":"Selinexor\n\n• Given orally at a dose of 60 mg on days 1, 8, and 15 of a 28-day cycle.\n\nDexamethasone\n\n* Given orally at a dose of 40 mg on days 1, 8, 15 and 22 of a 28-day cycle.\n* Subjects will receive a prescription for dexamethasone 4 mg tablets (generic).\n\nClarithromycin\n\n* Given orally at a dose of 500 mg twice a day on days 1-28 of a 28-day cycle.\n* Subjects will receive a prescription for clarithromycin 250 or 500 mg tablets (generic) for oral administration.\n\nPomalidomide\n\n* Given orally at a dose of 4 mg daily on days 1-21 of a 28-day cycle.\n* Subjects will receive a 21-day supply of pomalidomide 1, 2, 3, or 4 mg capsules for oral administration for each treatment cycle.\n\nSelinexor: Given as 60 mg oral capsule\n\nClarithromycin: Given as 500 mg oral capsule\n\nPomalidomide: Given as 4 mg oral capsule\n\nDexamethasone: Given as 40 mg oral capsule","id":"FG000","title":"Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Disease Progression"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"4"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"2"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"2"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}